JPRN-UMIN000016873Completed未知
Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS) - REWRAPS Study
Fujita Health University, Department of Cardiology0 sites300 target enrollmentStarted: March 23, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Those in whom the package inserts state anticoagulant drugs are contraindicated for use Those who are scheduled to undergo percutaneous coronary intervention or catheter ablation for AF Those who have to continuously undergo dual antiplatelet due to a past history of stent thrombosis during the distant stage after stenting Those who have undergone prosthetic valve replacement for valvular disease Those who the physician in charge judges are ineligible for the study due to serious pathological conditions Those who have moderate renal insufficiency (creatinine clearance less than 30 ml/min) Those who have severe hepatic insufficiency [ALT more than five times the upper limit of normal (ULN), or ALT more than three times ULN, plus total bilirubin more than three times ULN] Those who have anemia (hemoglobin less than 10 g/dl) Those who are not willing to participate in the study
Investigators
Similar Trials
Recruiting
Not Applicable
Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS:prospective observational study)Atrial fibrillation, Coronary artery diseaseJPRN-UMIN000024206Fujita Health University, Department of Cardiology1,600
Completed
Not Applicable
Prospective Registry of rivaroxaban management of cancer-associated venous thromboembolism studyCancer-associated venous ThromboembolismJPRN-UMIN000034933International University of Health and Welfare500
Recruiting
Not Applicable
Japanese registry of Rivaroxaban effectiveness & safety for the prevention of recurrence in patients with Deep Vein Thrombosis and Pulmonary EmbolismJPRN-UMIN000025072ihon University School of Medicine1,000
Completed
Not Applicable
Continuous Warfarin (Antithrombin therapy) administration versus Heparin bridge therapy in post colon polypectomy hemorrhagecolon polypJPRN-UMIN000023720Osaka City University Graduate School of Medicine316
Completed
Phase 2
Comparing efficacy of Rivaroxaban versus Warfarin on carotid plaqueIRCT20190729044372N1Kermanshah University of Medical Sciences60